Intro
Aduro (ADRO) is a biotechnology company with a focus on therapies designed to harness the body's natural immune system.
Product candidates from Aduro's two primary platforms (cGAS-STING and B-select monoclonal antibody) form a pipeline of clinical and preclinical candidates that allow the company to collaborate with leading global pharmaceutical companies like Merck (MRK), Eli Lilly (LLY), and Novartis (NVS).
With the market in panic mode as COVID-19 pandemic continues, the decline in Aduro Biotech's stock price could represent a great opportunity to open one long